IL17A and breast cancer: Recently studies suggested that IL-17 and its producing cells Th17 were disadvantageous factors in breast cancer by changing the behavior of tumor cells, eliciting tumorigenic neutrophils recruitment [59], promoting chemoresistance, proliferation of tumor cells [60], tumor angiogenesis [61] and metastasis [62].